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Ultrasound-targeted microbubble destruction (UTMD) has been proposed as a new technique for organ-speciﬁc gene transfer
and drug delivery. This study was performed to investigate the eﬀect of UTMD on marrow mesenchymal stem cells (MSCs)
transfected with pcDNA3.1−-hVEGF165.pcDNA3.1−-hVEGF165 were transfected into the third passage of MSCs, with or without
UTMD under diﬀerent ultrasound conditions.Protein expression was quantiﬁed by hVEGF165-ELISA kit after transfection for 24,
48, and 72hours. UTMD-mediated transfection of MSCs yielded a signiﬁcant protein expression. UTMD of mechanic index (MI)
0.6 for 90seconds led to the highest level of protein expression.
1.Introduction
Heart disease currently remains the leading cause of death
worldwide.Withthedevelopmentoftissueengineering,stem
cell technology has been widely used and highlights the
latestadvances intheseexcitingﬁelds [1].Mesenchymal stem
cells (MSCs) have demonstrated the ability to diﬀerentiate
into cardiomyocytes, but are still limited to construct the
vessels [2, 3]. Vascular endothelial growth factor (VEGF)
could induce vascular endothelial cell proliferation and
angiogenesis [4]. Because of its short half-life, VEGF could
not maintain eﬀective concentration in blood after injec-
tion [5]. In recent years, Ultrasound-targeted microbubble
destruction (UTMD) has been proved to be a promising
technique for organ-speciﬁc gene and drug delivery [6]. In
this experiment, we transferred pcDNA3.1−-hVEGF165 into
MSCs by UTMD and observed the eﬀect of the protein
expression.
2.Materialsand Methods
2.1. Separation and Cultivation of MSCs. Our experiment
was performed in the Clinical Research Center, the Second
Aﬃliated Hospital, School of Medicine, Zhejiang University,
China. Five male Sprague-Dawley rats, weighing 80–100g,
were provided by the animal center of Zhejiang University.
All experiments have adhered to the National Institutes of
Health guideforthe careand use oflaboratory animals (NIH
Publications no. 8023, revised 1978). Approval from the
Institutional Animal Care and Use Committee at Zhejiang
University Health Science Centre was also obtained to
perform the described experiments. MSCs were harvested
from the bone marrow of femurs of these rats. Brieﬂy,
bone marrow cells were ﬂushed out with 30mL complete
Dulbecco’s modiﬁed Eagle’s medium (DMEM, Gibco, USA)
containing 10% heat-inactivated fetal bovine serum (FBS,
Gibco, USA), 5mg/mL glutamine (Gibco, USA), 100U/mL2 Journal of Biomedicine and Biotechnology
penicillin(Gibco,USA),and100U/mLstreptomycin(Gibco,
USA). The cells were grown in a humidiﬁed atmosphere
containing 5% CO2 and 95% O2. The medium was replaced
24 hours later and refreshed every 2 days. Cells were sub-
cultured according to 1:2 ratio when they reached approx-
imately 80% conﬂuence by trypsinization (0.25% trypsin,
Gibco, USA). The third passage of MSCs was adopted for
transfection.
2.2. Recombinant pcDNA3.1−-hVEGF165 Gene Transfer into
MSCs by UTMD. The third passage of MSCs were planted
into three 6-well plate (Becton Dickinson, USA) at 1.0×
105 cells/per well and cultured for 24 hours in 37◦C, 5% CO2
conditions. Before transfection, 5mL normal saline were
added to the microbubble contrast agent SonoVue (Bracco,
Italy) powder (25mg) and thoroughly mixed for 20 seconds.
4µg/per well pcDNA3.1−-hVEGF165 recombinant (Future
Biotech, China) were mixed with 10mL lipofectamin 2000
transfection reagent (Invitrogen, USA) for 20s [7].
In this study, all the cells were divided intothe following
ﬁve groups:
(1) the blank control group: MSCs with culture ﬂuid,
(2) the control group A: 4µgp c D N A 3 . 1 −-hVEGF165 re-
combinant were transfected into MSCs,
(3) the control group B: 4µgp c D N A 3 . 1 −-hVEGF165 re-
combinant mixed with 300µl SonoVue microbubble
were transfected into MSCs,
(4) the control group C: 4µgp c D N A 3 . 1 −-hVEGF165 re-
combinant were transfected into MSCs by ultrasonic
exposure (illustrated by the example of mechanic
index (MI) 1.0 and exposure time (ET) 60s),
(5) the UTMD group: 4µgp c D N A 3 . 1 −-hVEGF165 re-
combinant were transfected into MSCs by UTMD
(MI 1.0, ET 60s).
The UTMD group was also divided into three groups accord-
ing to diﬀerent MI and ET.
Ultrasound-targeted microbubble was ruptured as fol-
lowing: Acuson Sequoia 512 ultrasound’s 3V2C transducer
(Siemens, German) was placed on the bottom of each well
plate according to the preset ultrasonic exposure condition.
The ultrasound parameters were set as follows: the frequency
was 4MHz, the depth was 4cm, MI was 0.6, 1.0, and 1.4
r e s p e c t i v e l y ,a n dE Tw a s3 0s ,6 0s ,a n d9 0s ,r e s p e c t i v e l y .
MSCs cultural supernatant was collected after transfec-
tion for 24, 48, and 72 hours, respectively. Five samples were
applied in each group.
2.3.DetectionofVEGF165 ProteinExpression afterTransfection
by ELISA Quantitative Assay. hVEGF165-ELISA kit (Jingmei,
China) was used to determine VEGF165 protein expression
after transfection for 24, 48, and 72 hours according to the
instructions.This was repeated ﬁve times in this experiment.
2.4. Statistical Analysis. All the parameters were expressed as
mean ± standard deviation. A one-way analysis of variance
Table 1: Protein expression of VEGF165 in mesenchymal stem cells
supernatant after transfection (n = 25, ng/mL).
Groups
Protein expression of VEGF165
24h 48h 72h
(1) The blank control
group 12.5 ±1.81 2 .1 ±0.61 1 .8 ±0.1
(2) The control group A 73.1 ±0.47 4 .0 ±1.27 0 .4 ±1.0
(3) The control group B 67.3 ±2.17 9 .4 ±0.87 4 .1 ±1.5
(4) The control group C 63.7 ±2.68 2 .1 ±1.77 6 .3 ±1.3
(5) The UTMD group 218.6 ±0.9∗ 269.2 ± 2.2∗ 199.4 ±2.1∗
∗P<. 05, versus each other non-UTMD groups.
(1) The blank control group: MSCs with culture ﬂuid.
(2) The control group A: 4µgp c D N A 3 . 1 −-hVEGF165 recombinant were
transfected into MSCs.
(3) The control group B: 4µgp c D N A 3 . 1 −-hVEGF165 recombinant mixed
with 300µl SonoVue microbubble were transfected into MSCs.
(4) The control group C: 4µgp c D N A 3 . 1 −-hVEGF165 recombinant were
transfected into MSCs by ultrasonic exposure (illustrated by the example of
Mechanic index (MI) 1.0 and exposure time (ET) 60s).
(5) The UTMD group: 4µgp c D N A 3 . 1 −-hVEGF165 recombinant were
transfected into MSCs by UTMD (MI 1.0, ET 60s).
(ANOVA), followed by a LSD (least signiﬁcant diﬀerence)
test was used to compare VEGF165 protein expression among
diﬀerent groups. All analyses were performed using SPSS
statistical software, version 13.0 (SPSS, Inc., USA). A two-
sided P<. 05 was considered statistically signiﬁcant.
3.Results
The results showed that the VEGF165 protein expression
increased at 24 hours and reached the maximum level at 48
hours, then decreased at 72 hours (Table 1). Compared with
the control group, protein expression of the UTMD group
was signiﬁcantly increased (P<. 05).
Table 2 also demonstrated that VEGF165 protein level
varied according to diﬀerent ultrasound conditions. The
group with ET 90s and MI 0.6 showed the highest protein
level at 48 hours, which has statistical signiﬁcance compared
with every group with ET 30s and MI 0.6, 1.0, and 1.4,
respectively (P<. 05).
4.Discussion
The lack of suitable autologous grafts has produced a
need for artiﬁcial grafts, but the patency of such grafts is
limited compared to natural materials. Tissue engineering,
whereby living tissue replacements can be constructed, has
emerged as a solution to some of these diﬃculties [8].
MSCs have demonstrated the ability to diﬀerentiate into
cardiomyocytes, This, in turn, is limited by the availability
of MSCs to construct the vessels [9].
VEGF,aclassofmolecularweightof34∼45KDglycopro-
tein, could induce vascular endothelial cell proliferation and
angiogenesis. VEGF165 protein-induced diﬀerentiation of
MSCs directional vascular endothelial cells plays a vital role
in neovascularization of ischemic tissues [10, 11]. However,
because of its short half-life, VEGF could not maintainJournal of Biomedicine and Biotechnology 3
Table 2: Protein expression of VEGF165 in mesenchymal stem cells supernatant after transfection under diﬀerent ultrasound conditions
(n = 25, ng/mL).
Various ultrasound conditions Protein expression of VEGF165
ET MI 24h 48h 72h
0.6 118.2 ±0.7 133.1 ±0.3 112.7 ±0.8
30s 1.0 140.5 ±1.1 142.0 ±0.5 131.5 ±0.1
1.4 136.6 ±0.7 154.1 ±1.1 121.8 ±0.9
0.6 177.6 ±1.2 168.8 ±2.3 159.1 ±0.8
60s 1.0 218.6 ±0.9 269.2 ±1.2 199.4 ±2.1
1.4 254.6 ±0.7 289.6 ±3.6 249.1 ±0.8
0.6 289.9 ±1.5∗ 319.1 ±2.1∗ 268.7 ±1.4∗
90s 1.0 161.2 ±1.8 186.5 ±0.8 151.6 ±1.3
1.4 160 .0 ± 3.5 175.2 ±1.6 148.2 ±2.5
∗P<. 05, versus groups with ET 30s and MI 0.6, 1.0, and 1.4, respectively.
eﬀective concentration in blood after injection because of
rapid degradation of deoxyribonucleic acid (DNA) [12–14].
Thus, intravenousinjection ofplasmid DNAdoesnot lead to
detectable transfection [15]. In the present study, UTMD, a
promising technique for organ-speciﬁc gene and drug deliv-
ery, was tried aiming to transfer VEGF into MSCs eﬃciently.
UT M Dh a sev ol v eda sapr om i s i n gt oolf oror ga n - s peci ﬁ c
geneand drugdelivery[16].This techniquehasinitially been
developed as a method in myocardial contrast echocardio-
graphy, destroying intramyocardial microbubbles to charac-
terizereﬁllkinetics.Whenloadingsimilarmicrobubbleswith
abioactivesubstance,ultrasonicdestructionofmicrobubbles
may release the transported substance in the targeted organ
[17].Furthermore,high-amplitudeoscillationsofmicrobub-
bles increased capillary and cell membrane permeability
and facilitated tissue and cell penetration of the released
substance [18–20].
As the target cell of gene transfer, MSCs could promote
expression of VEGF protein and vascularization of tissue
engineering bone by transfected VEGF165.V E G F 165 was
a kind of secretary protein, whether the transfected gene
could express eﬀectively was the critical point of the present
experiment.
Table 1 showed that VEGF165 protein production in-
creased after MSCs was transfected with VEGF165 by UTMD.
The VEGF165 protein expression reached maximum at
48 hours and decreased later, which had statistical sig-
niﬁcance compared with all other non-UTMD group at
all set moments (P<. 05). It could be explained by
three mechanisms: ﬁrstly, electron microscopy has demon-
strated pore formation on cell membranes immediately
after destruction of microbubbles, the pores are transient
and disappeared after 24 hours [21]. Such “sonoporation”
eﬀects may help facilitating gene or drug entry into the cell.
Studies on single bubbles in vitro have shown that even
linear bubble oscillations are suﬃcient to achieve rupture of
lipid membranes [22]. Secondly, sudden violent collapse of
microbubbles(inertial cavitation) can produce high-velocity
ﬂuid microjets that may penetrate adjacent membranes
[23]. Thirdly, inertial cavitation, which is dependent on
microbubble shell composition, ultrasound frequency, pulse
duration, and acoustic power, can lead to secondary shock
waves, transient local high temperatures, and shear stress, all
ofwhichcouldpotentiallycontributetogeneordrugdelivery
by UTMD [24, 25].
Table 2showed thatVEGF165 proteinlevelchangedunder
diﬀerent ultrasound conditions. The group with UTMD of
MI 0.6 for 90s showed the highest peak protein level at
48 hours, which has statistical signiﬁcance compared with
other groups with ET 30s. Studies have conﬁrmed that
the disruption force of microbubbles is greater when the
ultrasound frequency used matches the resonant frequency
of microbubbles. Even low acoustic pressures can result in
microbubble destruction, but higher pressures will lead to
more forceful reactions [26]. However, too higher acoustic
pressure will hurt the cells, this is why the VEGF165 protein
level of groups with MI 1.4, ET 90s was lower in this study.
5.Limitations
The ﬁrst limitation of this present study is that the number
of samples is small. However, even with this small number
ofsamples, we were able toreach ourprimary goal ofinvesti-
gating the proteinexpression ofUTMDon MSCstransfected
with pcDNA3.1−-hVEGF165. Secondly, the cell proliferation
and angiogenesis of transfected MSCs by UTMD will not
be traced, which is very important for tissue engineering.
Thirdly, thisstudyislimitedinvitro.Sofurther investigation,
especially in larger animal models, is needed.
6.Conclusion
UTMD-mediated transfection of MSCs yielded a signiﬁcant
protein expression. UTMD of mechanic index (MI) 0.6 for
90 seconds led to the highest level of protein expression.
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